Comparison of tissue-based and plasma-based testing for mutation in non–small cell lung cancer patients
Background Epidermal growth factor receptor (EGFR) gene mutation testing is crucial for the administration of tyrosine kinase inhibitors to treat non–small cell lung cancer. In addition to traditional tissue-based tests, liquid biopsies using plasma are increasingly utilized, particularly for detect...
Saved in:
Main Authors: | Yoon Kyung Kang, Dong Hoon Shin, Joon Young Park, Chung Su Hwang, Hyun Jung Lee, Jung Hee Lee, Jee Yeon Kim, JooYoung Na |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2025-01-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://www.jpatholtm.org/upload/pdf/jptm-2024-10-01.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of mutations in plasma cell-free DNA of colorectal cancer patients and comparison with cancer panel data for tissue samples of the same cancers
by: Suji Min, et al.
Published: (2019-11-01) -
Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
by: Jieun Lee, et al.
Published: (2017-03-01) -
Liquid biopsy in cancer management: Integrating diagnostics and clinical applications
by: Shashwat Pandey, et al.
Published: (2025-01-01) -
Potentialities and critical issues of liquid biopsy in clinical practice: An umbrella review
by: Nicola Veronese, et al.
Published: (2025-02-01) -
Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning
by: Ali Safi, et al.
Published: (2025-02-01)